Becton Dickinson and Company (BDX)

Becton Dickinson and Company (BDX $145.31)
- $145.31 P/E (TTM): 24.43X Cap: $41.37B
- View BDX Profile
- View Questions on BDX

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Becton Dickinson and Company (BDX $145.31)
- $145.31 P/E (TTM): 24.43X Cap: $41.37B
- View BDX Profile
- View Questions on BDX
Stryker Corporation (SYK $315.13)
- $315.13 P/E (TTM): 38.17X Cap: $120.68B
- View SYK Profile
- View Questions on SYK
Waters Corporation (WAT $292.13)
- $292.13 P/E (TTM): 27.95X Cap: $28.67B
- View WAT Profile
- View Questions on WAT
Zoetis Inc. Class A (ZTS $113.83)
- $113.83 P/E (TTM): 19.38X Cap: $47.88B
- View ZTS Profile
- View Questions on ZTS
Pfizer CDR (CAD Hedged) (PFE $11.85)
- $11.85 P/E (TTM): 19.47X Cap: $204.35B
- View PFE Profile
- View Questions on PFE
Merck CDR (CAD Hedged) (MRK $24.86)
- $24.86 P/E (TTM): 15.11X Cap: $371.99B
- View MRK Profile
- View Questions on MRK

Q: As portfolios should be diversified, the following names are owned, yet are not doing well, except SYK/MRK. Are any of these outright sells or just not the flavour of the day?Thank you for your excellent advice!

Read Answer Asked by Neil on April 29, 2026

Intuitive Surgical Inc. (ISRG $453.83)
- $453.83 P/E (TTM): 56.7X Cap: $160.72B
- View ISRG Profile
- View Questions on ISRG
Abbott Laboratories (ABT $91.33)
- $91.33 P/E (TTM): 25.23X Cap: $159.06B
- View ABT Profile
- View Questions on ABT
Becton Dickinson and Company (BDX $145.31)
- $145.31 P/E (TTM): 24.43X Cap: $41.37B
- View BDX Profile
- View Questions on BDX
Boston Scientific Corporation (BSX $57.15)
- $57.15 P/E (TTM): 30.13X Cap: $84.93B
- View BSX Profile
- View Questions on BSX
iShares U.S. Medical Devices ETF (IHI $50.33)
- $50.33 P/E (TTM): 36.71X Cap: $3.08B
- View IHI Profile
- View Questions on IHI

Q: Comments on earnings and if buy, sell or hold. What is happening with medical devices in the current economic environment? Thank you!

Read Answer Asked by Neil on May 06, 2025

Intuitive Surgical Inc. (ISRG $453.83)
- $453.83 P/E (TTM): 56.7X Cap: $160.72B
- View ISRG Profile
- View Questions on ISRG
Becton Dickinson and Company (BDX $145.31)
- $145.31 P/E (TTM): 24.43X Cap: $41.37B
- View BDX Profile
- View Questions on BDX
Stryker Corporation (SYK $315.13)
- $315.13 P/E (TTM): 38.17X Cap: $120.68B
- View SYK Profile
- View Questions on SYK

Q: Team, I have holdings in all three and although I have done great with BDX over the years, it seems to be struggling. I am thinking of selling but would like your comments on increasing my holdings in SYK and ISRG or would you provide insights another option. All three stocks are in my non registered account.
By the way, because of your insights on AMED of a few years ago, I sold the stock and purchased GOOG.............it was a great move
I have whittled down my holdings to 15 stocks and want to be careful adding more

Read Answer Asked by Roland on December 02, 2024